ThermoGenesis Holdings Shares Outstanding 2006-2021 | THMO

ThermoGenesis Holdings shares outstanding from 2006 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
ThermoGenesis Holdings Annual Shares Outstanding
(Millions of Shares)
2020 6
2019 3
2018 2
2017
2017 1
2016 0
2015 0
2014 0
2013 0
2012 0
2011 0
2010 0
2009 0
2008 0
2007 0
2006 0
2005 0
ThermoGenesis Holdings Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 12
2021-03-31 11
2020-12-31 6
2020-09-30 7
2020-06-30 6
2020-03-31 4
2019-12-31 3
2019-09-30 3
2019-06-30 3
2019-03-31 2
2018-12-31 2
2018-09-30 2
2018-06-30 2
2018-03-31 1
2017-12-31
2017-09-30 1
2017-06-30 1
2017-03-31 1
2016-12-31 1
2016-09-30 1
2016-06-30
2016-03-31 0
2015-12-31 0
2015-09-30 0
2015-06-30
2015-03-31 0
2014-12-31 0
2014-09-30 0
2014-06-30
2014-03-31 0
2013-12-31 0
2013-09-30 0
2013-06-30
2013-03-31 0
2012-12-31 0
2012-09-30 0
2012-06-30
2012-03-31 0
2011-12-31 0
2011-09-30 0
2011-06-30
2011-03-31 0
2010-12-31 0
2010-09-30 0
2010-06-30
2010-03-31 0
2009-12-31 0
2009-09-30 0
2009-06-30
2009-03-31 0
2008-12-31 0
2008-09-30 0
2008-06-30
2008-03-31 0
2007-12-31 0
2007-09-30 0
2007-06-30
2007-03-31 0
2006-12-31 0
2006-09-30 0
2006-06-30
2006-03-31 0
2005-12-31 0
2005-09-30 0
2005-06-30
2005-03-31 0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.025B $0.010B
ThermoGenesis Holdings Inc. develops, commercializes and markets automated technologies for CAR-T and other cell-based therapies. The company markets solutions for automated clinical biobanking, point-of-care applications and automation for immuno-oncology. ThermoGenesis Holdings Inc., formerly known as Cesca Therapeutics Inc., is based in Rancho Cordova, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.838B 8.91
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.341B 20.90
Biohaven Pharmaceutical Holding (BHVN) United States $8.723B 0.00
Emergent Biosolutions (EBS) United States $2.813B 6.79
Arcus Biosciences (RCUS) United States $2.568B 0.00
Myovant Sciences (MYOV) United Kingdom $2.170B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.949B 0.00
Zymeworks (ZYME) Canada $1.323B 0.00
Ambrx Biopharma (AMAM) United States $0.509B 0.00
SQZ Biotechnologies (SQZ) United States $0.428B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29